Position
Fidelity in Vir Biotechnology, Inc.
Back to the book · All holders of VIR
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $2.55M$8.96 → $10.19
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 3.16M | $19M | — | — | — | 0.0% |
| Q1 2026 | 2.07M | $18.6M | $8.96 | $6.07M | −$6.55M | 0.0% |
| Q2 2026 | 2.32M | $23.6M | $10.19 | $2.55M | $2.51M | 0.0% |